LogicBio Therapeutics Inc (LOGC) is near the bottom in its industry group according to InvestorsObserver. LOGC gets an overall rating of 35. That means it scores higher than 35 percent of stocks. LogicBio Therapeutics Inc gets a 23 rank in the Biotechnology industry. Biotechnology is number 54 out of 148 industries.

Click Here to get the full Stock Score Report on LogicBio Therapeutics Inc (LOGC) Stock.

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as good for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 35 means the stock is more attractive than 35 percent of stocks.

These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

LogicBio Therapeutics Inc (LOGC) stock is up 14.53% while the S&P 500 is down -0.34% as of 11:07 AM on Thursday, Jan 23. LOGC is up $1.11 from the previous closing price of $7.64 on volume of 206,086 shares. Over the past year the S&P 500 has risen 25.45% while LOGC is up 10.34%. LOGC lost -$2.49 per share the over the last 12 months.

To see the top 5 stocks in Biotechnology click here.

See the original post here:
Is LogicBio Therapeutics Inc (LOGC) a Winner or a Loser in the Biotechnology Industry - InvestorsObserver